These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
SCHEDULE 14A
|
||||
|
|
|
|
|
|
|
[ ]
|
Preliminary Proxy Statement
|
|
[ ]
|
Confidential, for Use of the Commission Only (as permitted by Rule 14a 6(e)(2))
|
|
[x]
|
Definitive Proxy Statement
|
|
[ ]
|
Definitive Additional Materials
|
|
[ ]
|
Soliciting Material under §240.14a 12
|
|
[x]
|
No fee required.
|
|
[ ]
|
Fee computed on table below per Exchange Act Rules 14a 6(i)(1) and 0-11.
|
|
(1)
|
Title of each class of securities to which transaction applies: ________________________________________________________________________________________
|
|
(2)
|
Aggregate number of securities to which transaction applies:
|
|
(3)
|
Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0‑11 (set forth the amount on which the filing fee is calculated and state how it was determined):
|
|
(4)
|
Proposed maximum aggregate value of transaction:
|
|
(5)
|
Total fee paid:
|
|
[ ]
|
Fee paid previously with preliminary materials.
|
|
[ ]
|
Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid previously. Identify the previous filing by registration statement number, or the Form or Schedule and the date of its filing.
|
|
(1)
|
Amount Previously Paid: _______________________________________________________________________________________
|
|
(2)
|
Form, Schedule or Registration Statement No.: _______________________________________________________________________________________
|
|
(3)
|
Filing Party: _______________________________________________________________________________________
|
|
(4)
|
Date Filed: _______________________________________________________________________________________
|
|
•
|
Item 1: to elect two
Class II
directors to serve until the Company’s
2020
Annual Meeting of Stockholders, or until such directors’ successors shall have been duly elected and qualified;
|
|
•
|
Item 2: to ratify the appointment of BDO USA, LLP as our independent registered public accounting firm for fiscal year 2017;
|
|
•
|
Item 3: the advisory approval of the compensation of the Company's named executive officers;
|
|
•
|
Item 4: the determination, on an advisory basis, of the frequency of future advisory votes to approve the Company’s executive compensation;
|
|
•
|
Item 5: to approve the amendment and restatement of our 2009 Stock Incentive Plan to increase the number of shares authorized for grant by 4,000,000 shares and to make certain changes thereto;
|
|
•
|
Item 6: to approve the amendment and restatement of our 2010 Employee Stock Purchase Plan to increase the number of shares authorized for employee purchase by 1,000,000 shares; and
|
|
•
|
to act upon such other business as may properly come before the Annual Meeting.
|
|
(1)
|
Election of two
Class II
directors to serve until the Company’s
2020
Annual Meeting of Stockholders, or until such directors’ successors shall have been duly elected and qualified;
|
|
(2)
|
Ratification of the appointment of BDO USA, LLP as the Company's independent registered public accounting firm for fiscal year 2017;
|
|
(3)
|
Advisory approval of the executive compensation of the Company’s named executive officers;
|
|
(4)
|
The determination, on an advisory basis, of the frequency of future advisory votes to approve the Company’s executive compensation;
|
|
(6)
|
Approval of the amendment and restatement of our 2010 Employee Stock Purchase Plan to increase the number of shares authorized for employee purchase by 1,000,000 shares; and
|
|
(7)
|
Transaction of such other business as may properly come before the Annual Meeting or any adjournments or postponements thereof.
|
|
YOUR VOTE IS VERY IMPORTANT, REGARDLESS OF THE NUMBER OF SHARES YOU OWN. PLEASE READ THE ATTACHED PROXY STATEMENT CAREFULLY, COMPLETE, SIGN AND DATE THE ENCLOSED PROXY CARD AS PROMPTLY AS POSSIBLE AND RETURN IT IN THE ENCLOSED ENVELOPE OR VOTE YOUR SHARES ON THE INTERNET.
|
|
(1)
|
the election of two
Class II
directors to serve until the Company’s
2020
Annual Meeting of Stockholders, or until such directors’ successors shall have been duly elected and qualified;
|
|
(2)
|
to ratify the appointment of BDO USA, LLP as the Company’s independent registered public accounting firm for fiscal year 2017;
|
|
(3)
|
advisory approval of the compensation of the Company’s named executive officers;
|
|
(4)
|
determination, on an advisory basis, of the frequency of future advisory votes to approve the Company’s executive compensation;
|
|
(6)
|
the approval of the amendment and restatement of our 2010 Employee Stock Purchase Plan to increase the number of shares authorized for employee purchase by 1,000,000 shares; and
|
|
(7)
|
action upon such other business as may properly come before the Annual Meeting or any adjournments or postponements thereof.
|
|
Class II
(current term ends at this Annual Meeting) |
|
Class III
(current term ends at the 2018 Annual Meeting) |
|
Class I
(current term ends at the 2019 Annual Meeting) |
|
Peter Block
|
|
Kevin C. Lavan
|
|
Jill Layfield
|
|
Fred Mossler
|
|
Robert P. LoCascio
|
|
William G. Wesemann
|
|
David Vaskevitch
|
|
|
|
|
|
•
|
All of the members of the Board other than Mr. LoCascio are “independent” under the Nasdaq rules.
|
|
•
|
All members of our Audit Committee, Compensation Committee, and Nominating and Corporate Governance Committee are independent.
|
|
•
|
The Board has adopted a Code of Conduct applicable to all of our employees, including our executive officers, as well as a Code of Ethics for the Chief Executive Officer and Senior Financial Officers. The Code of Conduct and Code of Ethics can be found at
www.liveperson.com/company/ir/corporate-governance
.
|
|
•
|
The Board has adopted a policy regarding conflicts of interest and “related-person transactions” under which all potential conflicts of interest and related-person transactions must be reviewed and pre-approved by the Audit Committee.
|
|
•
|
An annual risk assessment of the Company’s compensation policies is conducted by the Board and the Compensation Committee.
|
|
Audit Committee
|
|
Compensation Committee
|
|
Nominating and Corporate Governance Committee
|
|
Executive Committee
|
|
Kevin C. Lavan (Chair)
|
|
Peter Block (Chair)
|
|
Peter Block
|
|
Peter Block
|
|
Jill Layfield
|
|
Kevin C. Lavan
|
|
Kevin C. Lavan
|
|
Kevin C. Lavan
|
|
David Vaskevitch
|
|
Jill Layfield
|
|
Jill Layfield
|
|
Robert LoCascio
|
|
William G. Wesemann
|
|
Fred Mossler
|
|
Fred Mossler
|
|
William G. Wesemann
|
|
|
|
David Vaskevitch
|
|
David Vaskevitch
|
|
|
|
|
|
William G. Wesemann
|
|
William G. Wesemann (Chair)
|
|
|
|
•
|
the Company’s annual incentive compensation is based on balanced performance metrics that promote disciplined progress towards Company goals;
|
|
•
|
the Company does not offer significant short-term incentives that might drive high-risk investments at the expense of long-term Company value;
|
|
•
|
the Company’s long-term incentives do not drive high-risk investments at the expense of long-term Company value; and
|
|
•
|
the Company’s compensation programs are appropriately balanced between cash and equity, and the equity component does not promote unnecessary risk taking.
|
|
•
|
each person or group of affiliated persons whom we know to beneficially own more than five percent of our common stock;
|
|
•
|
each of our named executive officers identified in the “Summary Compensation Table” included in this Proxy Statement on page 23;
|
|
•
|
each of our directors and director nominees; and
|
|
•
|
each of our directors and executive officers as a group.
|
|
Name and Address
(1)
|
|
Number of
Shares Beneficially
Owned
(2)
|
|
Percentage of
Common Stock
Outstanding
(%)
|
|
5% Stockholders
|
|
|
|
|
|
BlackRock, Inc.
(3)
|
|
6,189,455
|
|
10.7%
|
|
RGM Capital, LLC
(4)
|
|
4,710,702
|
|
8.1%
|
|
The Vanguard Group
.(5)
|
|
4,468,769
|
|
7.7%
|
|
Discovery Equity Partners, L.P.
.(6)
|
|
3,656,394
|
|
6.3%
|
|
|
|
|
|
|
|
Named Executive Officers and Directors
|
|
|
|
|
|
Robert P. LoCascio
(7)
|
|
5,347,259
|
|
9.0%
|
|
Daniel Murphy
(8)
|
|
360,856
|
|
*
|
|
Eran Vanounou
(9)
|
|
130,625
|
|
*
|
|
Monica Greenberg
(9)
|
|
239,920
|
|
*
|
|
Dustin Dean
(9)
|
|
127,612
|
|
*
|
|
Peter Block
(10)
|
|
171,000
|
|
*
|
|
Kevin C. Lavan
(11)
|
|
161,000
|
|
*
|
|
Jill Layfield
(9)
|
|
35,000
|
|
*
|
|
David Vaskevitch
(9)
|
|
165,000
|
|
*
|
|
William G. Wesemann
(12)
|
|
300,000
|
|
*
|
|
Directors and Executive Officers as a group (11 persons)
(13)
|
|
7,099,897
|
|
11.7%
|
|
(1)
|
Unless noted otherwise, the business address of each beneficial owner is c/o LivePerson, Inc., 475 Tenth Avenue, 5
th
Floor, New York, New York 10018.
|
|
(2)
|
Beneficial ownership is determined in accordance with the rules of the SEC and includes voting and/or investment power with respect to the shares shown as beneficially owned.
|
|
(3)
|
Based solely on our review of the Schedule 13G/A filed with the SEC on January 12, 2017 by BlackRock, Inc., whose address is 55 East 52
nd
Street, New York, New York 10022.
|
|
(4)
|
Based solely on our review of the Schedule 13G/A filed with the SEC on February 14, 2017 by RGM Capital, LLC., whose address is 9010 Strada Stell Court, Suite 105, Naples, Florida 34109.
|
|
(5)
|
Based solely on our review of the Schedule 13G filed with the SEC on February 10, 2017 by The Vanguard Group, whose address is 100 Vanguard Blvd., Malvern, Pennsylvania 19355.
|
|
(6)
|
Based solely on our review of the Schedule 13D/A filed with the SEC on March 21, 2017 by Discovery Equity Partners, L.P., whose address is 300 South Wacker Drive, Suite 600, Chicago, Illinois 60606.
|
|
(7)
|
Of the total shares held by Mr. LoCascio, 4,646,983 shares of common stock are held indirectly by Mr. LoCascio through Ikon LP, a limited partnership of which Mr. LoCascio is the sole owner. Includes 678,149 shares underlying options that are currently exercisable or that will be exercisable and/or RSUs that have vested or that will vest, in each case at or within 60 days of April 13, 2017. 2,000,000 shares of common stock beneficially owned by Mr. LoCascio are pledged as collateral in connection with a line of credit extended to Mr. LoCascio by UBS.
|
|
(8)
|
Includes 355,006 shares underlying options that are currently exercisable or that will be exercisable and/or RSUs that have vested or that will vest, in each case at or within 60 days of April 13, 2017.
|
|
(9)
|
Reflects shares underlying options that are currently exercisable or that will be exercisable and/or RSUs that have vested or that will vest, in each case at or within 60 days of April 13, 2017.
|
|
(10)
|
Includes 165,000 shares of common stock issuable upon exercise of options presently exercisable or exercisable within 60 days of
April 13, 2017
.
|
|
(11)
|
Includes 155,000 shares of common stock issuable upon exercise of options presently exercisable or exercisable within 60 days of
April 13, 2017
.
|
|
(12)
|
Includes 20,000 shares of common stock that are owned of record by a family trust over which Mr. Wesemann has indirect beneficial ownership. Also includes 190,000 shares of common stock issuable upon exercise of options presently exercisable or exercisable within 60 days of
April 13, 2017
.
|
|
(13)
|
Includes 2,302,937 shares underlying options that are currently exercisable or that will be exercisable and/or RSUs that have vested or that will vest, in each case at or within 60 days of
April 13, 2017
and shares over which the directors and executive officers are indirect beneficial owners. Includes holdings of all directors and executive officers as a group including executive officers not listed above. Excludes holdings of Fred Mossler, who joined the Company's Board of Directors in May 2017.
|
|
Name
|
|
Age
|
|
Position(s)
|
|
Robert P. LoCascio
|
|
48
|
|
Chief Executive Officer and Chairman of the Board
|
|
Daniel R. Murphy
|
|
50
|
|
Chief Financial Officer
|
|
Eran Vanounou
|
|
46
|
|
Chief Technology Officer
|
|
Monica L. Greenberg
|
|
48
|
|
Executive Vice President, Business Affairs and General Counsel
|
|
Dustin Dean
|
|
46
|
|
Executive Vice President, Global Field Organization
|
|
Daryl J. Carlough
|
|
45
|
|
Senior Vice President, Global and Corporate Controller
|
|
•
|
Perquisites
. We generally do not provide special benefits, perquisites or supplemental retirement plans to our Named Executive Officers.
|
|
•
|
Tax Gross-Ups
. We generally do not provide any tax gross-ups to our Named Executive Officers.
|
|
•
|
Independence
. Our Compensation Committee is comprised solely of independent directors.
|
|
•
|
Periodic Review
. The Compensation Committee reviews our compensation practices and program to ensure that our Named Executive Officers are compensated in a manner consistent with our business strategy, competitive market practice, sound corporate governance principles and stockholder interests.
|
|
•
|
Risk Analysis
. Our executive compensation program is structured to avoid inappropriate risk taking by our Named Executive Officers by having the appropriate pay philosophy tied to reasonable business objectives. The Compensation Committee has concluded that the Company’s executive compensation program is reasonable, in the best interest of our stockholders, and not likely to have a material adverse effect on our Company.
|
|
•
|
Hedging
. Our Insider Trading Policy prohibits hedging of Company stock or the use of Company stock and any other transactions which could reasonably cause our officers to have interests adverse to our stockholders.
|
|
•
|
align incentives, including bonus targets, performance metrics and equity, with Company fiscal performance as well as achievement of strategic objectives that create stockholder value;
|
|
•
|
retain and encourage high potential team players to build a career at the Company;
|
|
•
|
provide incentives that are cost-efficient, competitive with other organizations and fair to employees and stockholders; and
|
|
•
|
design a balanced approach to compensation that properly aligns incentives with Company performance and stockholder value and does not promote inappropriate risk taking.
|
|
•
|
Base Salary - fixed pay that takes into account an individual’s role and responsibilities, experience, and expertise.
|
|
•
|
Annual Incentive - variable pay that is designed to reward attainment of annual business goals. Executives are eligible for an annual cash incentive payment and performance-based restricted stock units based on the achievement of a combination of Company performance as well as individual performance against defined objectives tied to the Company’s strategic and fiscal objectives. In the case of executives whose primary objective is revenue generation, incentive compensation may take the form of commissions tied to revenue as well as other Company and individual performance metrics.
|
|
•
|
Long-Term Incentives - the Company’s equity based incentive plan allows for awards that may include stock options, stock appreciation rights, restricted stock, performance shares and other stock based awards, including restricted stock units and deferred stock units. To date, the Company has used only stock options and restricted stock units for long-term incentive awards. Stock options are typically granted on or after the first year of service, and occasionally to new hires in key roles, and may also be granted from time to time during an employee’s continued tenure. Restricted stock units are granted on a discretionary basis from time to time as determined to be appropriate by the Compensation Committee. All equity awards granted to date are subject to certain vesting conditions, as described more fully below.
|
|
•
|
Benefits and Perquisites - the Company offers certain benefits, including medical, dental and life insurance benefits, a deferred compensation program, and retirement savings that it considers to be consistent with industry practices and important for competitive recruitment and retention. The named executive officers are eligible to participate in these programs on the same basis as our other employees. The Company does not generally offer special benefits such as supplemental executive retirement plans, perquisites, tax gross-ups or tax equalization.
|
|
1.
|
Base Salary
|
|
2.
|
Annual Incentive Compensation
|
|
•
|
earnings per share;
|
|
•
|
gross or net revenues;
|
|
•
|
revenue per employee;
|
|
•
|
adjusted EBITDA
(*)
;
|
|
•
|
adjusted EBITDA per share
(*)
;
|
|
•
|
attainment of strategic milestones;
|
|
•
|
attainment of product innovation or delivery objectives; or
|
|
•
|
such other goals established by the Committee.
|
|
3.
|
Long-term Incentives - Equity-Based Awards
|
|
4.
|
Other Benefits and Perquisites
|
|
Name and Principal Position
|
Year
|
Salary ($)
|
Stock Awards ($)
(1)
|
Option Awards ($)
(1)
|
Non-Equity Incentive Plan Compensation ($)
(2)
|
All Other Compensation ($)
|
|
Total
($) |
||||||
|
Robert P. LoCascio
Chief Executive Officer |
2016
|
540,536
|
|
—
|
|
—
|
|
380,000
|
|
17,096
|
|
(3)
|
937,632
|
|
|
2015
|
534,038
|
|
1,134,100
|
|
—
|
|
380,000
|
|
18,381
|
|
|
2,066,519
|
|
|
|
2014
|
511,538
|
|
—
|
|
477,750
|
|
475,000
|
|
6,430
|
|
|
1,470,718
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||
|
Daniel R. Murphy
Chief Financial Officer |
2016
|
420,536
|
|
—
|
|
—
|
|
157,500
|
|
20,174
|
|
(3)
|
598,210
|
|
|
2015
|
415,288
|
|
1,134,100
|
|
—
|
|
168,000
|
|
28,711
|
|
|
1,746,099
|
|
|
|
2014
|
387,785
|
|
—
|
|
477,750
|
|
210,000
|
|
25,293
|
|
|
1,100,828
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||
|
Eran Vanounou
(4)
Chief Technology Officer |
2016
|
348,372
|
|
—
|
|
—
|
|
94,603
|
|
64,473
|
|
(5)
|
507,448
|
|
|
2015
|
330,973
|
|
1,237,200
|
|
—
|
|
94,603
|
|
61,795
|
|
|
1,724,571
|
|
|
|
2014
|
312,318
|
|
—
|
|
694,122
|
|
130,000
|
|
57,366
|
|
|
1,193,806
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||
|
Monica L. Greenberg
Executive Vice President, Business Affairs and General Counsel |
2016
|
352,525
|
|
—
|
|
—
|
|
100,000
|
|
10,867
|
|
(3)
|
463,392
|
|
|
2015
|
347,928
|
|
670,150
|
|
—
|
|
100,000
|
|
13,870
|
|
|
1,131,948
|
|
|
|
2014
|
322,705
|
|
—
|
|
167,213
|
|
125,000
|
|
12,396
|
|
|
627,314
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||
|
Dustin Dean
Executive Vice President, Global Field Organization |
2016
|
335,416
|
|
—
|
|
—
|
|
—
|
|
192,475
|
|
(3) (6)
|
527,891
|
|
|
2015
|
335,416
|
|
1,031,000
|
|
—
|
|
227,500
|
|
418,136
|
|
|
2,012,052
|
|
|
|
(1)
|
Amounts represent the aggregate grant date fair value for restricted stock units and stock options granted in the fiscal year computed in accordance with Financial Accounting Standards Board’s Accounting Standards Codification Topic 718, or ASC Topic 718, and in accordance with SEC rules. Generally, the aggregate grant date fair value is the amount that the Company expects to expense in its financial statements over the award’s vesting schedule. These amounts reflect the Company’s accounting expense and do not correspond to the actual value that will be realized by the Named Executive Officers and there is no assurance that these grant date fair values will ever be realized by the Named Executive Officers. Pursuant to SEC rules, the amounts shown exclude the impact of estimated forfeitures related to service-based vesting conditions. For additional information on the valuation assumptions with respect to the grants, refer to Note 1 of LivePerson’s consolidated financial statements contained in our Annual Report on Form 10-K for the
2016
Fiscal Year, as filed with the SEC.
|
|
(2)
|
The performance-based, annual cash incentive bonuses earned in
2016
and paid in 2017 are reflected in the column entitled “Non-Equity Incentive Plan Compensation” for
2016
, those earned in 2015 and paid in
2016
are reflected in the column entitled “Non-Equity Incentive Plan Compensation” for 2015 and those earned in 2014 and paid in 2015 are reflected in the column entitled “Non-Equity Incentive Plan Compensation” for 2014.
|
|
(3)
|
Amount includes: (i) $
26
for premiums for term life insurance paid by us on behalf of Mr. LoCascio, Mr. Murphy, Ms. Greenberg, and Mr. Dean (ii) $
6,000
for matching contributions to 401(k) plans paid by us on behalf of Mr. LoCascio, Mr. Murphy, Ms. Greenberg, and Mr. Dean, and (iii) $
11,070
, $
14,148
, $
4,841
, and $
13,641
for Mr. LoCascio, Mr. Murphy, Ms. Greenberg, and Mr. Dean respectively, for health, dental, vision and disability insurance.
|
|
(4)
|
Payments to Mr. Vanounou were made in Israeli New Shekels, or NIS. For the 2016 Fiscal Year, an average exchange rate of approximately U.S. $1.00/NIS
3.84
was used to calculate amounts for Mr. Vanounou with respect to amounts under “Salary,” “Non-Equity Incentive Plan Compensation,” and "All Other Compensation".
|
|
(5)
|
Amount includes: (i) $
18,393
for employer contributions to Mr. Vanounou’s executive insurance fund, (ii) $
5,859
for employer contributions to Mr. Vanounou’s education fund, (iii) $
1,711
for employer contribution to Mr. Vanounou’s disability insurance, (iv) $
9,416
for employer contribution to the Israeli National Insurance Fund (vi) $
28,504
for statutory contributions to Mr. Vanounou’s severance fund, and (vii) $
590
paid as a convalescence allowance as required under Israeli labor law.
|
|
(6)
|
This amount includes: (i) $70,808 tax-equalization payment of Australian taxes, and (ii) $102,000 housing expenses
.
|
|
Named Executive Officer
|
|
Reason for Payment
|
|
Salary-Related Payments
($)
|
|
Bonus-Related Payments ($)
|
|
Accelerated
Vesting of Equity
Awards
($)
|
|
Other Benefits
($)
|
|
||||
|
Robert P. LoCascio
|
|
Termination without cause or for good reason (regardless of whether a change of control occurred)
|
|
540,000
|
|
(1)
|
475,000
|
|
(2)
|
—
|
|
|
—
|
|
|
|
Daniel R. Murphy
|
|
Termination without cause or for good reason, not following a change of control
|
|
210,000
|
|
(3)
|
210,000
|
|
(4)
|
—
|
|
|
—
|
|
|
|
|
|
Termination without cause or for good reason, following a change in control
|
|
210,000
|
|
(5)
|
210,000
|
|
(4)
|
294,922
|
|
(6)
|
—
|
|
|
|
Eran Vanounou
(7)
|
|
Termination without cause or constructively terminated (regardless of whether a change of control occurred)
|
|
116,124
|
|
(8)
|
—
|
|
|
—
|
|
|
—
|
|
|
|
Monica L. Greenberg
|
|
Termination without cause or constructively terminated, not following a change of control
|
|
176,000
|
|
(9)
|
—
|
|
|
283,125
|
|
(10)
|
4,301
|
|
(11)
|
|
|
|
Termination without cause or constructively terminated, following a change in control
|
|
264,000
|
|
(12)
|
—
|
|
|
283,125
|
|
(10)
|
4,301
|
|
(11)
|
|
(1)
|
Represents Mr. LoCascio’s annual base salary as of December 31,
2016
. If Mr. LoCascio is terminated by us without “cause” or Mr. LoCascio terminates his employment for “good reason,” we must pay him an amount equal to 12 months of his then current base salary for the fiscal year in which the termination occurred. This amount is payable in three equal monthly installments beginning 30 days after his termination. “Cause” means (i) an act or acts of dishonesty, moral
|
|
(2)
|
Represents Mr. LoCascio’s 2016 Fiscal Year target bonus. If Mr. LoCascio is terminated by us without “cause” or Mr. LoCascio terminates his employment for “good reason,” we must pay him an amount equal to the pro rata portion of the bonus he would have been entitled to receive for the fiscal year in which the termination occurred. This amount is payable in three equal monthly installments beginning 30 days after his termination.
|
|
(3)
|
Represents Mr. Murphy’s base salary as of December 31,
2016
for 6 months. If Mr. Murphy is terminated by us without “cause” or Mr. Murphy terminates his employment for “good reason,” then subject to executing a release of claims, he is entitled to receive his then-current base salary for a period of 6 months following such termination. The term “cause” in Mr. Murphy’s employment agreement means a determination by the Company (which determination shall not be arbitrary or capricious) that: (i) he materially failed to perform his specified or fundamental duties to us or any of our subsidiaries, (ii) he was convicted of, or pled nolo contendere to, a felony (regardless of the nature of the felony), or any other crime involving dishonesty, fraud, or moral turpitude, (iii) he engaged in or acted with gross negligence or willful misconduct (including but not limited to acts of fraud, criminal activity or professional misconduct) in connection with the performance of his duties and responsibility to us or any our subsidiaries, (iv) he failed to substantially comply with the rules and policies of the Company or any of our subsidiaries governing employee conduct or with the lawful directives of the Board of Directors, or (v) he breached any non-disclosure, non-solicitation or other restrictive covenant obligation to us or any of our subsidiaries. If, in our reasonable discretion, we determine that an event or incident described in clause (i) or (iv) above is curable, then in order to terminate Mr. Murphy’s employment for cause pursuant to clause (i) or (iv) above, we will (a) provide Mr. Murphy with written notice of the event or incident that we consider to be “cause” within 30 calendar days following its occurrence, (b) provide Mr. Murphy with a period of at least 15 calendar days to cure the event or incident, and (c) if the cause persists following the cure period, terminate Mr. Murphy’s employment by written termination letter any time within 60 calendar days following the date that notice to cure was delivered to Mr. Murphy. The term “good reason” under Mr. Murphy’s employment agreement means one of more of the following conditions arising without his consent and subject to certain notice and cure periods: (a) a material reduction in his base salary, other than as part of an across-the-board reduction applicable to other similarly situated employees; (b) a material diminution in role, responsibilities and title; or (iii) a relocation of our principal office to a location more than 50 miles from our location on such date (or from such other location to which he has consented after the date of the agreement).
|
|
(4)
|
Represents Mr. Murphy’s 2016 Fiscal Year target bonus. If Mr. Murphy is terminated by us without “cause” or Mr. Murphy terminates his employment for “good reason” at any time on or before the date that bonuses for the prior fiscal year are paid, we must pay him an amount equal to the bonus he would have been entitled to receive for the prior fiscal year had he remained employed on the date bonuses for such fiscal year are paid.
|
|
(5)
|
Represents Mr. Murphy’s base salary as of December 31,
2016
for 6 months. If there is a change of control of the Company and Mr. Murphy is terminated by us without “cause” or Mr. Murphy terminates his employment for “good reason,” in each case within 12 months following the change of control, then subject to executing a release of claims, he is entitled to receive the following severance: (i) his then-current base salary for a period of 6 months following such termination and (ii) his outstanding options and/or other equity awards that are scheduled to vest in the 24-month period following his termination will accelerate and become exercisable upon such termination and will remain exercisable for up to 90 days following his termination.
|
|
(6)
|
Represents the closing price of our common stock on December 31,
2016
less the exercise price for the options and stock awards held by Mr. Murphy, multiplied by the number of shares underlying the options that would otherwise vest over the following 24 months.
|
|
(7)
|
Payments to Mr. Vanounou are made in Israeli New Shekels, or NIS. For this disclosure, an average exchange rate of approximately U.S. $1.00/NIS 3.84 was used to calculate amounts for Mr. Vanounou.
|
|
(8)
|
Represents Mr. Vanounou’s base salary as of December 31,
2016
for 120 days. If Mr. Vanounou is terminated by us without “cause”, then subject to executing a release of claims, he will be entitled to 120 days’ notice, or at the option of the Company a lump sum severance payment equal to 120 days of his then current base salary. The term “cause” in Mr. Vanounou’s employment agreement has substantially the same definition as provided above for Mr. Murphy.
|
|
(9)
|
Represents Ms. Greenberg’s base salary as of December 31,
2016
for 6 months. If Ms. Greenberg is terminated by us without “cause,” or Ms. Greenberg is “constructively terminated,” then subject to executing a release of claims, she is entitled to receive the following severance: (i) a lump sum severance payment equal to 6 months of her then current base salary, (ii) all of her outstanding options will accelerate and become exercisable upon such termination and will remain exercisable for up to 12 months following her termination, and (iii) up to 6 months of premium payments for health insurance coverage under COBRA. The term “cause” in Ms. Greenberg’s employment agreement has substantially the same definition as provided above for Mr. Murphy. The term “constructively terminated” under her employment agreement means one of more of the following conditions arising without her consent and subject to certain notice and cure periods: (a) a relocation of our primary offices outside a radius that is 40 miles from our current offices; or (b) a material diminution of her job responsibilities or level of authority or base salary.
|
|
(10)
|
Represents the closing price of our common stock on December 31,
2016
less the exercise price for the options and stock awards held by Ms. Greenberg, multiplied by the total number of unvested shares underlying the options.
|
|
(11)
|
Represents up to 6 months of premium payments for health insurance coverage under COBRA.
|
|
(12)
|
Represents Ms. Greenberg’s base salary as of December 31,
2016
for 9 months. If there is a change of control of the Company and Ms. Greenberg is terminated by us without “cause” or Ms. Greenberg is “constructively terminated,” in each case within 12 months following the change of control, then subject to executing a release of claims, she will be entitled to receive the same severance benefits as described above except the lump sum severance payment will be equal to 9 months (instead of 6 months) of her then current base salary.
|
|
Name
|
|
Estimated Future Payouts
Under
Non-Equity Incentive Plan
Awards
|
|
|||||||
|
|
Threshold
($)
|
|
Target
($)
(1)
|
|
Maximum
($)
|
|
||||
|
Robert P. LoCascio
|
|
—
|
|
|
475,000
|
|
|
—
|
|
|
|
|
|
|
|
|
|
|
|
|||
|
Daniel R. Murphy
|
|
—
|
|
|
210,000
|
|
|
—
|
|
|
|
|
|
|
|
|
|
|
|
|||
|
Eran Vanounou
|
|
—
|
|
|
186,406
|
|
|
—
|
|
|
|
|
|
|
|
|
|
|
|
|||
|
Monica L. Greenberg
|
|
—
|
|
|
125,000
|
|
|
—
|
|
|
|
|
|
|
|
|
|
|
|
|||
|
Dustin Dean
|
|
—
|
|
|
—
|
|
|
—
|
|
|
|
(1)
|
Amounts shown represent the target awards that could have been earned by the Named Executive Officer under the Company’s annual cash incentive bonus plan for these executives. There were no threshold or maximum bonus opportunities. The target amount could be exceeded based on performance metrics. Awards are based on achievement of individual performance objectives, Company performance as measured by adjusted EBITDA and the achievement of
|
|
|
|
Option Awards
|
|
Stock Awards
|
||||||||||||||
|
Name
|
|
Number of Securities Underlying Unexercised
Options (#)
Exercisable
(1)
|
|
Number of Securities Underlying Unexercised
Options (#)
Unexercisable
(1)
|
|
Option Exercise Price ($)
|
|
Option Expiration Date
|
|
Number of Shares or Unit of Stock That Have Not Vested (#)
(2)
|
|
Market Value of Shares or Units of Stock That Have Not Vested ($)
(3)
|
||||||
|
Robert P. LoCascio
|
|
25,000
|
|
|
—
|
|
|
1.79
|
|
|
3/5/2019
|
|
|
—
|
|
|
—
|
|
|
|
|
400,000
|
|
|
—
|
|
|
13.28
|
|
|
4/22/2021
|
|
|
—
|
|
|
—
|
|
|
|
|
100,000
|
|
|
—
|
|
|
16.98
|
|
|
9/4/2022
|
|
|
—
|
|
|
—
|
|
|
|
|
52,500
|
|
|
17,500
|
|
|
9.24
|
|
|
7/1/2023
|
|
|
—
|
|
|
—
|
|
|
|
|
50,000
|
|
|
50,000
|
|
|
10.13
|
|
|
4/25/2024
|
|
|
—
|
|
|
—
|
|
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
62,500
|
|
|
471,875
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||
|
Daniel R. Murphy
|
|
100,000
|
|
|
—
|
|
|
13.03
|
|
|
5/2/2021
|
|
|
—
|
|
|
—
|
|
|
|
|
100,000
|
|
|
—
|
|
|
16.98
|
|
|
9/4/2022
|
|
|
—
|
|
|
—
|
|
|
|
|
52,500
|
|
|
17,500
|
|
|
9.24
|
|
|
7/1/2023
|
|
|
—
|
|
|
—
|
|
|
|
|
50,000
|
|
|
50,000
|
|
|
10.13
|
|
|
4/25/2024
|
|
|
—
|
|
|
—
|
|
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
62,500
|
|
|
471,875
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||
|
Eran Vanounou
|
|
55,000
|
|
|
55,000
|
|
|
13.37
|
|
|
2/9/2024
|
|
|
—
|
|
|
—
|
|
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
68,750
|
|
|
519,063
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||
|
Monica L. Greenberg
|
|
93,750
|
|
|
—
|
|
|
3.45
|
|
|
2/22/2018
|
|
|
—
|
|
|
—
|
|
|
|
|
17,000
|
|
|
—
|
|
|
1.79
|
|
|
3/5/2019
|
|
|
—
|
|
|
—
|
|
|
|
|
20,750
|
|
|
—
|
|
|
7.02
|
|
|
6/17/2020
|
|
|
—
|
|
|
—
|
|
|
|
|
23,000
|
|
|
—
|
|
|
11.33
|
|
|
9/1/2021
|
|
|
—
|
|
|
—
|
|
|
|
|
25,000
|
|
|
—
|
|
|
16.98
|
|
|
9/4/2022
|
|
|
—
|
|
|
—
|
|
|
|
|
18,750
|
|
|
6,250
|
|
|
9.24
|
|
|
7/1/2023
|
|
|
—
|
|
|
—
|
|
|
|
|
17,500
|
|
|
17,500
|
|
|
10.13
|
|
|
4/25/2024
|
|
|
—
|
|
|
—
|
|
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
37,500
|
|
|
283,125
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||
|
Dustin Dean
|
|
8,700
|
|
|
—
|
|
|
3.23
|
|
|
4/1/2018
|
|
|
—
|
|
|
—
|
|
|
|
|
5,000
|
|
|
—
|
|
|
1.79
|
|
|
3/5/2019
|
|
|
—
|
|
|
—
|
|
|
|
|
8,300
|
|
|
—
|
|
|
7.02
|
|
|
6/17/2020
|
|
|
—
|
|
|
—
|
|
|
|
|
11,600
|
|
|
—
|
|
|
16.98
|
|
|
9/4/2022
|
|
|
—
|
|
|
—
|
|
|
|
|
11,250
|
|
|
3,750
|
|
|
9.24
|
|
|
7/1/2023
|
|
|
—
|
|
|
—
|
|
|
|
|
40,000
|
|
|
40,000
|
|
|
10.13
|
|
|
4/25/2024
|
|
|
—
|
|
|
—
|
|
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
56,250
|
|
|
424,688
|
|
|
(1)
|
The total original number of shares subject to each stock option grant listed above vests as to 25% of the original number of shares covered by each stock option grant on the first anniversary of the grant date of each stock option (the “
Grant Date
”) and as to an additional 25% of the original number of shares at the end of each successive anniversary of the Grant Date until the fourth anniversary of the Grant Date, subject to the executive's continued service with the Company through each vesting date and any acceleration provisions set forth in each executive’s employment agreement as described above in “Employment Agreement for our Named Executive Officers.”
|
|
(2)
|
The total original number of units subject to each restricted stock unit award listed above vests over four years, with 25% of the units vesting on the first anniversary of the grant date (the “
Grant Date
”) and the balance vesting in equal quarterly installments over the following 36 months.
|
|
(3)
|
The market value of unvested restricted stock units is based on the closing market price of the Company's Common Stock on December 31,
2016
of $7.55.
|
|
|
|
Option Awards
|
|
Stock Awards
|
||||
|
Name
|
|
Number of Shares Acquired on Exercise (#)
|
|
Value Realized on Exercise ($)
(1)
|
|
Number of Shares Acquired on Vesting (#)
(2)
|
|
Value Realized on Vesting ($)
(3)
|
|
Robert P. LoCascio
|
|
55,000
|
|
143,000
|
|
33,750
|
|
254,813
|
|
Daniel R. Murphy
|
|
—
|
|
—
|
|
33,750
|
|
254,813
|
|
Eran Vanounou
|
|
—
|
|
—
|
|
—
|
|
—
|
|
Monica Greenberg
|
|
75,000
|
|
202,500
|
|
22,500
|
|
169,875
|
|
Dustin Dean
|
|
11,000
|
|
28,600
|
|
33,750
|
|
254,813
|
|
Name
|
|
Fees
Earned
or Paid
in Cash
($)
|
|
Option
Awards
($)
(1)(2)
|
|
Total
($)
|
|
|
Peter Block
|
|
46,000
|
|
92,100
|
|
138,100
|
|
|
Kevin C. Lavan
|
|
55,000
|
|
92,100
|
|
147,100
|
|
|
Jill Layfield
|
|
—
|
|
126,700
|
|
126,700
|
|
|
David Vaskevitch
|
|
40,000
|
|
92,100
|
|
132,100
|
|
|
William G. Wesemann
|
|
50,000
|
|
92,100
|
|
142,100
|
|
|
(1)
|
This column represents the aggregate grant date fair value of stock options granted to each non-employee director in the 2016 Fiscal Year computed in accordance with FASB ASC Topic 718, and in accordance with SEC rules. Generally, the aggregate grant date fair value is the amount that the Company expects to expense in its financial statements over the award’s vesting schedule. These amounts reflect the company’s accounting expense and do not correspond to the actual value that will be realized by the non-employee directors and there is no assurance that these grant date fair values will ever be realized by the non-employee directors. Pursuant to SEC rules, the amounts shown exclude the impact of estimated forfeitures related to service-based vesting conditions. For additional information on the valuation assumptions with respect to the grants, refer to Note 1(l) of LivePerson’s consolidated financial statements contained in our Annual Report on Form 10-K for the
2016
Fiscal Year, as filed with the SEC.
|
|
(2)
|
As of December 31,
2016
, the number of shares underlying unexercised stock options were: Mr. Block, 165,000; Mr. Lavan, 155,000; Mr. Vaskevitch 165,000; and Mr. Wesemann, 190,000.
|
|
•
|
none of the members of the Compensation Committee was an officer (or former officer) or employee of the Company or any of its subsidiaries;
|
|
•
|
none of the members of the Compensation Committee had a direct or indirect material interest in any transaction in which the Company was a participant and the amount involved exceeded $120,000;
|
|
•
|
none of our executive officers served on the compensation committee (or another board committee with similar functions or, if none, the entire board of directors) of another entity where one of that entity’s executive officers served on our Compensation Committee;
|
|
•
|
none of our executive officers was a director of another entity where one of that entity’s executive officers served on our Compensation Committee; and
|
|
•
|
none of our executive officers served on the compensation committee (or another board committee with similar functions or, if none, the entire board of directors) of another entity where one of that entity’s executive officers served as a director on our Board of Directors.
|
|
Fiscal Years 2016 and 2015 Accounting Fees
|
||||||||
|
Fees
|
|
2016 Fiscal Year
|
|
2015 Fiscal Year
|
||||
|
Audit Fees
(1)
|
|
$
|
603,310
|
|
|
$
|
613,558
|
|
|
Audit-Related Fees
(2)
|
|
$
|
17,450
|
|
|
$
|
17,425
|
|
|
Tax Fees
(3)
|
|
$
|
16,400
|
|
|
$
|
—
|
|
|
All Other Fees
(4)
|
|
$
|
—
|
|
|
$
|
—
|
|
|
(1)
|
“
Audit Fees
” consists of fees for professional services rendered in connection with the audit of the Company’s consolidated annual financial statements, the review of the Company’s interim condensed consolidated financial statements included in quarterly reports, the audits in connection with statutory and regulatory filings or engagements and the audit of the Company’s internal controls over financial reporting.
|
|
(2)
|
“
Audit-Related Fees
” consists primarily of fees for professional services rendered in connection with the audits of the Company’s employee benefit plan and acquisition accounting due diligence.
|
|
(3)
|
“
Tax Fees
” consists of fees billed for professional services rendered for tax compliance, tax consulting and tax planning services.
|
|
(4)
|
“
All Other Fees
” - none.
|
|
•
|
The Incentive Plan includes a share counting provision whereby each restricted stock and restricted stock unit award (or other “full value”) granted will count as though 1.5 shares have been issued for purposes of monitoring share usage, limiting the Incentive Plan’s potential dilution impact on stockholders.
|
|
•
|
The Incentive Plan share reserve does not benefit from liberal share recycling provisions, and the limited recycling provision specifically prohibits shares of common stock used by a participant to cover the payment of the exercise price of a stock option and tax obligations related to an award from being added back to the number of shares available for future award grants.
|
|
•
|
The Company recognizes that “evergreen” share reserve provisions have the potential for built-in dilution to stockholder value. Therefore to address potential stockholder concerns, the Incentive Plan does not include an “evergreen” share reserve provision.
|
|
•
|
The Incentive Plan includes specific performance goals and limitations on the number of shares and the value of awards that may be granted under the Incentive Plan so that awards granted under the Incentive Plan may be designed to qualify as qualified performance-based compensation under Section 162(m) of the Code. These provisions will allow the Company to maximize the income tax deductions that it may take for awards issued under the Incentive Plan.
|
|
•
|
The Incentive Plan limits the overall number of shares of common stock that may be used with respect to grants to directors that are not employees of the Company at the time of grant.
|
|
•
|
Stock options and stock appreciation rights granted under the Incentive Plan must be granted with an exercise price (or measurement price, as applicable) that is not less than the fair market value of a share of our common stock on the date of grant.
|
|
•
|
The exercise price of any outstanding award may not be reduced, whether through amendment, cancellation or replacement grants with options, other awards and/or cash, or by any other means without stockholder approval.
|
|
•
|
Restricted stock and restricted stock unit awards and other stock or cash-based awards are subject to certain minimum vesting requirements. Specifically, such awards with solely time-based vesting must generally vest over at least a 3-year period from the date of grant and such awards that do not vest solely based on the passage of time must generally vest over at least a 1-year period from the date of grant, except that such limitations will not apply to such awards granted with respect to up to 5% of the total shares authorized for issuance under the Incentive Plan.
|
|
•
|
The Incentive Plan provides that any dividend and dividend equivalent rights provided as part of a restricted stock or restricted stock unit award, may not allow for dividends to be paid currently, but rather all such dividends must be accrued and paid only when and if the underlying award vests.
|
|
•
|
The Board may, in an award agreement, subject any award to a clawback provision;
|
|
•
|
The Incentive Plan does not provide for an automatic “single-trigger” acceleration of vesting on unvested awards in the event of a change in control of the Company.
|
|
•
|
The Incentive plan does not provide any tax-gross ups to participants.
|
|
Name of Individual or Group
|
|
Number of Options Granted (#)
|
|
Average Per Share Exercise Price ($)
|
|
Number of Shares subject to Restricted Stock Awards and/or Restricted Stock Units (#)
|
|
Dollar Value of Shares subject to Restricted Stock Awards and/or Restricted Stock Units ($)
|
||||||
|
|
|
|
|
|
|
|
|
|
||||||
|
All executive officers, as a group
|
|
—
|
|
|
$
|
—
|
|
|
—
|
|
|
$
|
—
|
|
|
All directors who are not executive officers, as a group
|
|
155,000
|
|
|
$
|
7.49
|
|
|
—
|
|
|
$
|
—
|
|
|
All employees who are not executive officers, as a group
|
|
635,250
|
|
|
$
|
7.26
|
|
|
513,650
|
|
|
$
|
3,246,268
|
|
|
Name of Individual or Group
|
|
Number of shares Purchased (#)
|
|
Weighted Average Purchase Price per Share ($)
|
|||
|
|
|
|
|
|
|||
|
All executive officers, as a group
|
|
—
|
|
|
$
|
—
|
|
|
All directors who are not executive officers, as a group
|
|
—
|
|
|
$
|
—
|
|
|
All employees who are not executive officers, as a group
|
|
183,325
|
|
|
$
|
5.88
|
|
|
•
|
although depreciation and amortization are non-cash charges, the assets being depreciated and amortized may have to be replaced in the future, and adjusted EBITDA does not reflect cash capital expenditure requirements for such replacements or for new capital expenditure requirements;
|
|
•
|
adjusted EBITDA does not reflect changes in, or cash requirements for, our working capital needs;
|
|
•
|
adjusted EBITDA does not consider the potentially dilutive impact of equity-based compensation;
|
|
•
|
adjusted EBITDA does not consider the impact of acquisition costs;
|
|
•
|
adjusted EBITDA does not consider the impact of restructuring costs;
|
|
•
|
adjusted EBITDA does not consider the impact of other non-recurring costs;
|
|
•
|
adjusted EBITDA does not reflect tax payments that may represent a reduction in cash available to us; and
|
|
•
|
other companies, including companies in our industry, may calculate adjusted EBITDA differently, which reduces its usefulness as a comparative measure.
|
|
|
Year Ended December 31,
|
||||||
|
|
2016
|
|
2015
|
||||
|
Reconciliation of Adjusted EBITDA:
|
|
|
|
||||
|
Net loss
|
$
|
(25,873
|
)
|
|
$
|
(26,444
|
)
|
|
Amortization of purchased intangibles
|
6,673
|
|
|
8,040
|
|
||
|
Stock-based compensation
|
9,736
|
|
|
11,814
|
|
||
|
Contingent earn-out adjustments
|
—
|
|
|
(3,680
|
)
|
||
|
Restructuring costs
|
2,369
|
|
|
3,384
|
|
||
|
Depreciation
|
12,011
|
|
|
12,114
|
|
||
|
Other non-recurring costs
|
7,818
|
|
|
—
|
|
||
|
Provision for income taxes
|
5,934
|
|
|
15,814
|
|
||
|
Acquisition costs
|
—
|
|
|
—
|
|
||
|
Other expense (income), net
|
530
|
|
|
202
|
|
||
|
Adjusted EBITDA
|
$
|
19,198
|
|
|
$
|
21,244
|
|
|
(1)
|
Dividends
.
|
|
(A)
|
Subject to Section 7(c)(1)(C) below, Participants holding shares of Restricted Stock will be entitled to all ordinary cash dividends paid with respect to such shares, unless otherwise provided by the Board.
|
|
(B)
|
Subject to Section 7(c)(1)(C) below, if any dividends or distributions are paid in shares, or consist of a dividend or distribution to holders of Common Stock other than an ordinary cash dividend, the shares, cash or other property will be subject to the same restrictions on transferability and forfeitability as the shares of Restricted Stock with respect to which they were paid.
|
|
(C)
|
Each dividend amount shall be credited to an account for the Participant and shall become payable if and when the Restricted Stock to which it relates vests or, if later, when the shareholders actually receive that dividend payment. Any such amount shall be paid within 30 days of the applicable vesting event or shareholder payment date, if later.
|
|
(2)
|
Voting Rights
. A Participant shall have no voting rights with respect to any Restricted Stock Units.
|
|
(3)
|
Dividend Equivalents
.
|
|
(A)
|
Subject to Section 7(d)(3)(C) below, to the extent provided by the Board, in its sole discretion, a grant of Restricted Stock Units may provide Participants with the right to receive an amount equal to any dividends or other distributions declared and paid on an equal number of outstanding shares of Common Stock (“
Dividend Equivalents
”).
|
|
(B)
|
Subject to Section 7(d)(3)(C) below, Dividend Equivalents may be settled in cash and/or shares of Common Stock, as determined by the Board in its sole discretion, and will be subject to the same restrictions on transfer and forfeitability as the Restricted Stock Units with respect to which paid, subject in each case to such terms and conditions as the Board shall establish, in each case to be set forth in the applicable Award agreement.
|
|
(C)
|
To the extent a Dividend Equivalent right is provided in an award agreement, each Dividend Equivalent shall be credited to an account for the Participant and become payable if and when the Restricted Stock Units to which it relates vest (and shall be paid at the same time as settlement of the Restricted Stock Units) or, if later, when the shareholders actually receive the corresponding dividend payment.
|
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
| FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
|---|
| DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
|---|
No information found
Customers
| Customer name | Ticker |
|---|---|
| Anthem, Inc. | ANTM |
No Suppliers Found
Price
Yield
| Owner | Position | Direct Shares | Indirect Shares |
|---|